Lexitas Pharma Services’ Post

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

For those living with sickle cell, innovative treatments are making a difference. From gene therapy and bone marrow transplants to new medications and pain management techniques, the results are life-changing. Many patients experience fewer pain crises and improved quality of life. Stay informed, stay hopeful, and let's continue supporting advancements in sickle cell care. #SickleCellAwareness #TreatmentOptions #HealthcareInnovation #HopeAndHealing

On Duchenne Muscular Dystrophy (DMD) day, we wanted to shine a light on the progressive genetic disorder that primarily affects boys. DMD is caused by a lack of dystrophin, a protein essential for muscle function. This leads to muscle weakness, wasting, and eventually difficulty breathing. Despite the challenges faced by those with DMD, there is hope on the horizon. There are currently over 67 ongoing global clinical trials (phases I-III) involving 55 drug compounds. These trials explore potential treatments, including gene therapy, exon skipping, and small molecule therapies. Let's come together to support research, raise awareness, and advocate for a future where DMD is no longer a barrier to living a full and active life. Together, we can make a difference. At Skills Alliance, we're proud to partner with innovators who are working to address this and other challenging health conditions. For more information on this genetic disorder, check out the United Nations: https://lnkd.in/eZFwuMNZ #DuchenneAwareness #MuscularDystrophy #HopeForACure #SkillsAlliance

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy

Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy